Vincent Aita

Develops early clinical-stage therapies for metabolic, inflammatory diseases and cancer

Kilkenny Capital Management takes long positions in undervalued US small/mid-cap biotechnology companies and short positions in overvalued stocks in the same sector. The firm maintains a very high turnover rate

HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services.

Functions as a College/University

Functions as a College/University

Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence.

Critical Mass Partners manages a long/short equity hedge fund that focuses on investments in the healthcare, industrial and consumer sectors.

EGM seeks to generate attractive absolute and risk-adjusted returns on invested capital over a multi-year period through a research intensive, data-driven quantitative and systematic trading and investment program.

Cutter Capital Management’s investment strategy focuses on market and factor neutral investing, long and short, in US and European equities markets (including related derivatives and exchange-traded funds (ETFs)), with a focus on investments in the healthcare sector.